DIVERSITY IN THE TUMOR GENOME AND MICROENVIRONMENT AS DRIVERS OF DCIS PROGRESSION
Investigating Recurrence of Invasive Cancer in Ductal Carcinoma In Situ (DCIS) Patients
Brief description of study.
The study will compare cases of DCIS that either did or did not recur as invasive cancer.
Detailed description of study
The study will compare cases of DCIS that either did or did not recur as invasive cancer.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: metastatic cancer
-
Age: 100 years or below
-
Gender: All
This study investigates ductal carcinoma in situ (DCIS), a condition where abnormal cells are found in the lining of a breast duct. The purpose of the study is to compare cases of DCIS that either did or did not recur as invasive cancer.
Participants will undergo various study procedures to collect data on DCIS cases and their outcomes. The study aims to understand the factors contributing to whether DCIS recurs as invasive cancer.
- Who can participate: Individuals aged 18 and older with a history of ductal carcinoma in situ (DCIS), either with or without recurrence as invasive cancer, may be eligible to participate.
- Study details: Participants will be required to provide medical history and undergo assessments to evaluate their DCIS condition. The study may involve collecting samples and other relevant information.